GALAPAGOS Trademark

Trademark Overview


On Monday, September 10, 2018, a trademark application was filed for GALAPAGOS with the United States Patent and Trademark Office. The USPTO has given the GALAPAGOS trademark a serial number of 88110392. The federal status of this trademark filing is REGISTERED as of Tuesday, October 22, 2019. This trademark is owned by Galapagos N.V.. The GALAPAGOS trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

pharmaceutical substances and preparations for human use, namely, for the treatment of bone cartilage and joint disease, autoinflammation diseases, autoimmune diseases, proliferative diseases, endocrine diseases, metabolic diseases, skin diseases, lung diseases, fibrotic diseases, cardiovascular diseases, pain, hepatitis B virus, kidney diseases, osteoporosis, osteoarthritis, rheumatoid arthritis, atopic dermatitis, idiopathic pulmonary fibrosis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, lupus, uveitis, scleroderma, non-alcoholic steatohepatitis, polycystic kidney disease, type 2 diabetes; biopharmaceutical substances and preparations for human use, namely, for the treatment of bone cartilage and joint disease, autoinflammation diseases, autoimmune diseases, proliferative diseases, endocrine diseases, metabolic diseases, skin diseases, lung diseases, fibrotic diseases, cardiovascular diseases, pain,...

medical services; medical and pharmaceutical advisory and consultancy services; gene bank services

medical and scientific research services; industrial research services in the field of assay development, target discovery and validation, drug development, and medicinal chemistry; pharmaceutical and biopharmaceutical research and development services; medical and scientific research, namely, the examination and testing of genes; development, laboratory analysis, and testing of pharmaceutical and biopharmaceutical semi-finished products for use in medicaments; development, laboratory analysis, and testing of medicaments; the development of clinical assays, cellular tests, testing kits, diagnostic kits, and companion diagnostics for evaluating pharmaceutical and biopharmaceutical products of others; development of computer databases in the medical, pharmaceutical and biopharmaceutical fields and gathering of data to populate same via collection of medical, pharmaceutical, biopharmaceutical research and clinical trial data; and gene bank services for research purposes
galapagos

General Information


Serial Number88110392
Word MarkGALAPAGOS
Filing DateMonday, September 10, 2018
Status700 - REGISTERED
Status DateTuesday, October 22, 2019
Registration Number5888518
Registration DateTuesday, October 22, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 6, 2019

Trademark Statements


Goods and Servicespharmaceutical substances and preparations for human use, namely, for the treatment of bone cartilage and joint disease, autoinflammation diseases, autoimmune diseases, proliferative diseases, endocrine diseases, metabolic diseases, skin diseases, lung diseases, fibrotic diseases, cardiovascular diseases, pain, hepatitis B virus, kidney diseases, osteoporosis, osteoarthritis, rheumatoid arthritis, atopic dermatitis, idiopathic pulmonary fibrosis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, lupus, uveitis, scleroderma, non-alcoholic steatohepatitis, polycystic kidney disease, type 2 diabetes; biopharmaceutical substances and preparations for human use, namely, for the treatment of bone cartilage and joint disease, autoinflammation diseases, autoimmune diseases, proliferative diseases, endocrine diseases, metabolic diseases, skin diseases, lung diseases, fibrotic diseases, cardiovascular diseases, pain, hepatitis B virus, kidney diseases, osteoporosis, osteoarthritis, rheumatoid arthritis, atopic dermatitis, idiopathic pulmonary fibrosis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, lupus, uveitis, scleroderma, non-alcoholic steatohepatitis, polycystic kidney disease, type 2 diabetes
Goods and Servicesmedical services; medical and pharmaceutical advisory and consultancy services; gene bank services
Goods and Servicesmedical and scientific research services; industrial research services in the field of assay development, target discovery and validation, drug development, and medicinal chemistry; pharmaceutical and biopharmaceutical research and development services; medical and scientific research, namely, the examination and testing of genes; development, laboratory analysis, and testing of pharmaceutical and biopharmaceutical semi-finished products for use in medicaments; development, laboratory analysis, and testing of medicaments; the development of clinical assays, cellular tests, testing kits, diagnostic kits, and companion diagnostics for evaluating pharmaceutical and biopharmaceutical products of others; development of computer databases in the medical, pharmaceutical and biopharmaceutical fields and gathering of data to populate same via collection of medical, pharmaceutical, biopharmaceutical research and clinical trial data; and gene bank services for research purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 17, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 17, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 17, 2018
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGalapagos N.V.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMechelen BE-2800
BE

Party NameGalapagos N.V.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMechelen BE-2800
BE

Party NameGalapagos N.V.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMechelen BE-2800
BE

Trademark Events


Event DateEvent Description
Tuesday, October 22, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, August 6, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 6, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 17, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 2, 2019ELECTRONIC RECORD REVIEW COMPLETE
Friday, June 28, 2019ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Monday, June 24, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 10, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 10, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 5, 2019TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, May 27, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 27, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 27, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 8, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 8, 2019NON-FINAL ACTION E-MAILED
Tuesday, January 8, 2019NON-FINAL ACTION WRITTEN
Wednesday, December 19, 2018ASSIGNED TO EXAMINER
Monday, October 22, 2018PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, October 18, 2018ASSIGNED TO LIE
Tuesday, October 9, 2018TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, September 17, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 13, 2018NEW APPLICATION ENTERED